Avanos Medical (AVNS) Shareholder's Equity Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.83% |
| Dec 31, 2025 | 886.06% |
| Sep 30, 2025 | -36.73% |
| Jun 30, 2025 | 89.81% |
| Mar 31, 2025 | 365.80% |
| Dec 31, 2024 | -108.01% |
| Sep 30, 2024 | 0.62% |
| Jun 30, 2024 | -345.39% |
| Mar 31, 2024 | -908.95% |
| Dec 31, 2023 | -4.25% |
| Sep 30, 2023 | -3.28% |
| Jun 30, 2023 | -104.31% |
| Mar 31, 2023 | -101.92% |
| Dec 31, 2022 | 1.62% |
| Sep 30, 2022 | -0.28% |
| Jun 30, 2022 | 25.79% |
| Mar 31, 2022 | 29.90% |
| Dec 31, 2021 | 0.67% |
| Sep 30, 2021 | -1.77% |
| Jun 30, 2021 | 14,248.91% |
| Mar 31, 2021 | 2,781.02% |
| Dec 31, 2020 | -0.83% |
| Sep 30, 2020 | 1.82% |
| Jun 30, 2020 | -6.98% |
| Mar 31, 2020 | 82.15% |
| Dec 31, 2019 | -1.90% |
| Sep 30, 2019 | -2.56% |
| Jun 30, 2019 | -100.55% |
| Mar 31, 2019 | -116.87% |
| Dec 31, 2018 | 6.73% |
| Sep 30, 2018 | 10.12% |
| Jun 30, 2018 | 35.52% |
| Mar 31, 2018 | 37.70% |
| Dec 31, 2017 | 10.24% |
| Sep 30, 2017 | 7.19% |
| Jun 30, 2017 | 6.18% |
| Mar 31, 2017 | 4.73% |
| Dec 31, 2016 | 4.47% |
| Sep 30, 2016 | 5.81% |
| Jun 30, 2016 | -28.41% |
| Mar 31, 2016 | -28.58% |
| Dec 31, 2015 | -29.23% |
| Sep 30, 2015 | -49.93% |
| Dec 31, 2014 | -28.28% |
| Sep 30, 2014 | -1.54% |